| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/10/2004 | US20040110218 BMOG, a novel protein member of the myelin-oligodendrocyte glycoprotein family and its use for immunomodulatory purposes |
| 06/10/2004 | US20040110213 Scaffold oligonucleotide; enables end-specific attachment without need for purifying; use in genetic probes |
| 06/10/2004 | US20040110202 Isolated nucleic acid comprising a polynucleotide of given sequence encoding a polypeptide; culturing cell line which alters a beta processing; use in treatment of Alzheimer's disease. |
| 06/10/2004 | US20040110201 Compositions and methods for cDNA synthesis |
| 06/10/2004 | US20040110196 to extend the life and slow the rate of oxidation of signal generating dyes and labels including fluorescent molecules used in association with assay substrates; coating is an ethyl methacrylate-methyl methacrylate copolymer transparent to signal |
| 06/10/2004 | US20040110192 Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencing |
| 06/10/2004 | US20040110190 Isolated nucleic acid comprising a polynucleotide encoding a polypeptide which has expansin activity; altering properties which may effect growth, flexibility, and mechanical strength in tissues in which they are expressed; use in paper industry |
| 06/10/2004 | US20040110185 Human hypothalmic ("HR") receptor polypeptide compositions, methods and uses thereof |
| 06/10/2004 | US20040110184 Identifying insecticidal protein specific to lepidopteran pests; cry proteins as biological pest control agents |
| 06/10/2004 | US20040110182 Process for improving efficiency of DNA amplification reaction |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110178 Method of screening for agents that regulate the shedding of membrane bound proteins and methods of use |
| 06/10/2004 | US20040110177 Method for identifying functional nucleic acids |
| 06/10/2004 | US20040110176 Fused protein having beta 1,2-n-acetylglucosaminyltransferase II activity and process for producing the same |
| 06/10/2004 | US20040110175 Comprises nucleotide sequences coding protein for use in treatment, diagnosis and prevention of nervous system disorders and neurodegenerative diseases; neuroprotectants |
| 06/10/2004 | US20040110174 Concatenated expression cassettes and vectors for controllable and co-ordinated expression of large numbers of heterologous genes in a single host cell |
| 06/10/2004 | US20040110173 Haplotype partitioning in the proximal promoter of the human growth hormone (GH1) gene |
| 06/10/2004 | US20040110171 Identifying transcriptional regulators which control axonal guidance for use as treatments of age related neurodegenerative diseases |
| 06/10/2004 | US20040110169 Method for rapid detection and identification of bioagents |
| 06/10/2004 | US20040110168 Diagnostics and therapeutics for osteoporosis |
| 06/10/2004 | US20040110164 L-methionine $g(g)-lyase with modified function |
| 06/10/2004 | US20040110162 Primer extension methods for detecting nucleic acids |
| 06/10/2004 | US20040110161 Identifying genetic aberrations in nucleic acid sequences using base mispairing-binding proteins; genomics |
| 06/10/2004 | US20040110160 Modulation of SEDL expression |
| 06/10/2004 | US20040110159 Antisense oligonucleotides for controlling expression of estrogen responsive transcription factor and for treatment of hyperproliferative disorders |
| 06/10/2004 | US20040110158 Modulation of mitochondrial ribosomal protein L13 expression |
| 06/10/2004 | US20040110157 Antisense oligonucleotides for controlling expression of thiolase and for treatment of disorders asociated with elevated cholesterol |
| 06/10/2004 | US20040110156 Antisense oligonucleotides for controlling expression of nuclear factor-kappaB repressing factor (NRF) and for treatment of immunological disorders |
| 06/10/2004 | US20040110151 Modulation of sentrin-2 expression |
| 06/10/2004 | US20040110150 Antisense oligonucleotides for controlling expression of tyrosine kinase interacting protein (EPHRIN-B2) and for treatment of hyperproliferative disorders |
| 06/10/2004 | US20040110149 Modulation of BUB1-beta expression |
| 06/10/2004 | US20040110148 Antisense oligonucleotides for controlling expression of polyamine biosynthetic enzymes and for treating hyperproliferative disorders |
| 06/10/2004 | US20040110147 Modulation of BAF53 expression |
| 06/10/2004 | US20040110146 Antisense oligonucleotides for controlling expression of cell surface adhesion molecule and for treatment of autoimmune disorders |
| 06/10/2004 | US20040110145 Modulation of MALT1 expression |
| 06/10/2004 | US20040110144 Modulation of EMAP-II expression |
| 06/10/2004 | US20040110143 Antisense oligonucleotides for controlling expression of liver receptor homologue -1 (LRH-1) for treatment of hyperproliferative disorders |
| 06/10/2004 | US20040110142 Modulation of AAC-11 expression |
| 06/10/2004 | US20040110140 Modulation of CDK9 expression |
| 06/10/2004 | US20040110139 Modulation of G protein-coupled receptor 3 expression |
| 06/10/2004 | US20040110137 Using fluorescent-light intensity waveform data to determine sequence of target nucleic acids; identifying restriction fragment length polymorphisms |
| 06/10/2004 | US20040110135 Method for producing linear DNA fragments for the in vitro expression of proteins |
| 06/10/2004 | US20040110132 Method for concentrate nucleic acids |
| 06/10/2004 | US20040110130 Population of polynucleotide sequence variants |
| 06/10/2004 | US20040110127 Screening methods for identifying compounds which decrease HIV entry into a cell |
| 06/10/2004 | US20040110126 Hcv polymerase inhibitor assay |
| 06/10/2004 | US20040110121 Plant-signalling ligand like proteins |
| 06/10/2004 | US20040109884 Polymers containing silane groups |
| 06/10/2004 | US20040109877 Rna viruses; attenuation influenza virus |
| 06/10/2004 | US20040109875 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 06/10/2004 | US20040109873 Genetic engineering equine herpes virus; genes coding protein |
| 06/10/2004 | US20040109871 Gene, immunogen transfer ; induction mucous membrane immunity; polynucleotide sequences ; bactericides, viricides, fungicides, parasirtici des, anticancer agents |
| 06/10/2004 | US20040109861 Isolated protein complexes; screening analyzing; human t-cell leukemia virus |
| 06/10/2004 | US20040109858 Conformation-specific anti-von Willebrand factor antibodies |
| 06/10/2004 | US20040109857 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 06/10/2004 | US20040109856 Diagnosis, therapy cancer, tumors |
| 06/10/2004 | US20040109848 Modulation of AP-2 alpha expression |
| 06/10/2004 | US20040109843 Pharmaceutical composition containing decoy and use of the same |
| 06/10/2004 | US20040109842 hybrid dendrimer having a poly(propyleneimine) interior and a poly(amidoamine) exterior complexed with guest molecule comprising a nucleic acid molecule, a metal, and/or a drug |
| 06/10/2004 | US20040107796 Plasma-assisted melting |
| 06/10/2004 | CA2854831A1 Treatment of mammalian reaction to ige interactions |
| 06/10/2004 | CA2796924A1 Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors |
| 06/10/2004 | CA2704070A1 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 06/10/2004 | CA2511481A1 Method of designing polynucleotides for rna interference |
| 06/10/2004 | CA2507728A1 Cell extract of escherichia coli having mutation in s12 ribosomal protein and process for producing protein in cell-free system using the same |
| 06/10/2004 | CA2507606A1 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna) |
| 06/10/2004 | CA2507469A1 Porcine polymorphisms and methods for detecting them |
| 06/10/2004 | CA2507460A1 Nucleic acid comprising a sequence encoding a modified glutenin polypeptide |
| 06/10/2004 | CA2507241A1 Protein production in transgenic avians |
| 06/10/2004 | CA2507125A1 Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors |
| 06/10/2004 | CA2507115A1 Treatment of mammalian reaction to ige interactions |
| 06/10/2004 | CA2506820A1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 06/10/2004 | CA2506798A1 Compositions and systems for the regulation of genes |
| 06/10/2004 | CA2506763A1 Method for expressing inducible rnai in cells, nucleic acid molecules therefor and cells transformed by said molecules |
| 06/10/2004 | CA2506714A1 Delivery of sirnas |
| 06/10/2004 | CA2506666A1 Nact as a target for lifespan expansion and weight reduction |
| 06/10/2004 | CA2506525A1 Hepatisis c virus nonstructural protein 4a (ns4a) is an enhancer element |
| 06/10/2004 | CA2506411A1 Inhibitors of gst a3-3 and gst a1-1 for the treatment of cancer |
| 06/10/2004 | CA2506356A1 Methods of therapy and diagnosis |
| 06/10/2004 | CA2505764A1 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 06/10/2004 | CA2505534A1 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 06/10/2004 | CA2504633A1 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same |
| 06/10/2004 | CA2504561A1 Composition and method for treating lupus nephritis |
| 06/10/2004 | CA2504144A1 Compositions and methods for the diagnosis of immune related diseases using pro7 |
| 06/10/2004 | CA2504010A1 Sequence specific dna recombination in eukaryotic cells |
| 06/10/2004 | CA2502718A1 A role in lignification and growth for plant phenylcoumaran benzylic ether reductase |
| 06/10/2004 | CA2501168A1 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 06/10/2004 | CA2476691A1 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | CA2460388A1 Method of efficient recombination of orf encoded in cdna, and template vector, trap vector and primer used thereto |
| 06/10/2004 | CA2452785A1 Sequence display method and homology search method for facilitating access to information relating to regions of mutation and regions of similarity between plurality of sequences |
| 06/09/2004 | EP1426444A2 Use of the angiogenic factor VEGF145 in treating cardiovascular diseases |
| 06/09/2004 | EP1426443A1 Novel human bmcc1 gene |
| 06/09/2004 | EP1426442A1 Marker molecules associated with colorectal lesions |
| 06/09/2004 | EP1426441A1 Alpha-1,2-fucosyl transferase and dna encoding the same |
| 06/09/2004 | EP1426440A1 Novel rfrp-3 and dna thereof |
| 06/09/2004 | EP1426438A1 Method of detecting toxic substance |
| 06/09/2004 | EP1426381A1 An epithelial protein and DNA thereof for use in early cancer detection |
| 06/09/2004 | EP1426110A2 Temperature-regulating block with temperature-regulating devices |
| 06/09/2004 | EP1426055A1 Targeted protein degradation vehicles (tpdvs), nucleic acid constructs encoding them and their use |